context
stringlengths 21
24.6k
| category
stringclasses 2
values | entity
stringlengths 1
12
| entity_type
stringclasses 5
values | query
stringlengths 97
3.31k
| answer
stringlengths 12
168
|
|---|---|---|---|---|---|
On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. </context> | us-gaap:DebtInstrumentFaceAmount |
On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. | text | 3.875 | percentItemType | text: <entity> 3.875 </entity> <entity type> percentItemType </entity type> <context> On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. | text | 550 | monetaryItemType | text: <entity> 550 </entity> <entity type> monetaryItemType </entity type> <context> On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. </context> | us-gaap:DebtInstrumentFaceAmount |
On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. | text | 4.125 | percentItemType | text: <entity> 4.125 </entity> <entity type> percentItemType </entity type> <context> On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. | text | 918 | monetaryItemType | text: <entity> 918 </entity> <entity type> monetaryItemType </entity type> <context> On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. </context> | us-gaap:ProceedsFromIssuanceOfLongTermDebt |
On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. | text | 879 | monetaryItemType | text: <entity> 879 </entity> <entity type> monetaryItemType </entity type> <context> On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. </context> | us-gaap:LongTermDebt |
On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. | text | 932 | monetaryItemType | text: <entity> 932 </entity> <entity type> monetaryItemType </entity type> <context> On May 15, 2023, the Company issued € 300 million 3.875 % Notes due 2026 (“2026 Notes”) and € 550 million 4.125 % Notes due 2031 (“2031 Notes”). The proceeds from the 2026 Notes and 2031 Notes were received in euros and converted to U.S. dollars on the date of issuance. The net proceeds received were approximately $ 918 million and will be used for general corporate purposes. As of December 31, 2024 and 2023, the U.S. dollar equivalent carrying value of the euro-denominated long-term debt was $ 879 million and $ 932 million, respectively. </context> | us-gaap:LongTermDebt |
Corning has defined benefit pension plans covering certain domestic and international employees. The Company may contribute, as necessary, an amount exceeding the minimum requirements to achieve the Company’s long-term funding targets. During the year ended December 31, 2024, no voluntary cash contributions were made to domestic plans and cash contributions of $ 9 million were made to international pension plans. During the year ended December 31, 2023, no voluntary cash contributions were made to domestic plans and cash contributions of $ 25 million were made to international defined benefit plans. In 2025, the Company plans to make cash contributions of $ 10 million to international pension plans. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> Corning has defined benefit pension plans covering certain domestic and international employees. The Company may contribute, as necessary, an amount exceeding the minimum requirements to achieve the Company’s long-term funding targets. During the year ended December 31, 2024, no voluntary cash contributions were made to domestic plans and cash contributions of $ 9 million were made to international pension plans. During the year ended December 31, 2023, no voluntary cash contributions were made to domestic plans and cash contributions of $ 25 million were made to international defined benefit plans. In 2025, the Company plans to make cash contributions of $ 10 million to international pension plans. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
Across total pension benefits, an actuarial gain of $ 0.1 billion was recognized in 2024 primarily due to increases in bond yields during the year, leading to domestic plan weighted-average discount rates that were 51 basis points higher than 2023, partially offset by international plan weighted-average discount rates that were 20 basis points lower than 2023. In 2023, an actuarial loss of $ 0.1 billion was recognized primarily due to decreases in bond yields during the year, leading to domestic and international plan weighted-average discount rates that were 34 and 16 basis points lower, respectively, than 2022. The accumulated benefit obligation for defined benefit pension plans was $ 3.6 billion and $ 3.7 billion as of December 31, 2024 and 2023, respectively. | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> Across total pension benefits, an actuarial gain of $ 0.1 billion was recognized in 2024 primarily due to increases in bond yields during the year, leading to domestic plan weighted-average discount rates that were 51 basis points higher than 2023, partially offset by international plan weighted-average discount rates that were 20 basis points lower than 2023. In 2023, an actuarial loss of $ 0.1 billion was recognized primarily due to decreases in bond yields during the year, leading to domestic and international plan weighted-average discount rates that were 34 and 16 basis points lower, respectively, than 2022. The accumulated benefit obligation for defined benefit pension plans was $ 3.6 billion and $ 3.7 billion as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DefinedBenefitPlanActuarialGainLoss |
Across total pension benefits, an actuarial gain of $ 0.1 billion was recognized in 2024 primarily due to increases in bond yields during the year, leading to domestic plan weighted-average discount rates that were 51 basis points higher than 2023, partially offset by international plan weighted-average discount rates that were 20 basis points lower than 2023. In 2023, an actuarial loss of $ 0.1 billion was recognized primarily due to decreases in bond yields during the year, leading to domestic and international plan weighted-average discount rates that were 34 and 16 basis points lower, respectively, than 2022. The accumulated benefit obligation for defined benefit pension plans was $ 3.6 billion and $ 3.7 billion as of December 31, 2024 and 2023, respectively. | text | 3.6 | monetaryItemType | text: <entity> 3.6 </entity> <entity type> monetaryItemType </entity type> <context> Across total pension benefits, an actuarial gain of $ 0.1 billion was recognized in 2024 primarily due to increases in bond yields during the year, leading to domestic plan weighted-average discount rates that were 51 basis points higher than 2023, partially offset by international plan weighted-average discount rates that were 20 basis points lower than 2023. In 2023, an actuarial loss of $ 0.1 billion was recognized primarily due to decreases in bond yields during the year, leading to domestic and international plan weighted-average discount rates that were 34 and 16 basis points lower, respectively, than 2022. The accumulated benefit obligation for defined benefit pension plans was $ 3.6 billion and $ 3.7 billion as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation |
Across total pension benefits, an actuarial gain of $ 0.1 billion was recognized in 2024 primarily due to increases in bond yields during the year, leading to domestic plan weighted-average discount rates that were 51 basis points higher than 2023, partially offset by international plan weighted-average discount rates that were 20 basis points lower than 2023. In 2023, an actuarial loss of $ 0.1 billion was recognized primarily due to decreases in bond yields during the year, leading to domestic and international plan weighted-average discount rates that were 34 and 16 basis points lower, respectively, than 2022. The accumulated benefit obligation for defined benefit pension plans was $ 3.6 billion and $ 3.7 billion as of December 31, 2024 and 2023, respectively. | text | 3.7 | monetaryItemType | text: <entity> 3.7 </entity> <entity type> monetaryItemType </entity type> <context> Across total pension benefits, an actuarial gain of $ 0.1 billion was recognized in 2024 primarily due to increases in bond yields during the year, leading to domestic plan weighted-average discount rates that were 51 basis points higher than 2023, partially offset by international plan weighted-average discount rates that were 20 basis points lower than 2023. In 2023, an actuarial loss of $ 0.1 billion was recognized primarily due to decreases in bond yields during the year, leading to domestic and international plan weighted-average discount rates that were 34 and 16 basis points lower, respectively, than 2022. The accumulated benefit obligation for defined benefit pension plans was $ 3.6 billion and $ 3.7 billion as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation |
For the years ended December 31, 2024 and 2023, postretirement benefits actuarial gains of $ 32 million and $ 7 million, respectively, were recognized. The increase in actuarial gain recognized is primarily due to changes in weighted-average discount rates in response to bond yields during the year. For the years ended December 31, 2024 and 2023, the changes in weighted-average discount rates were an increase of 42 basis points and a decrease of 34 basis points, respectively. | text | 32 | monetaryItemType | text: <entity> 32 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024 and 2023, postretirement benefits actuarial gains of $ 32 million and $ 7 million, respectively, were recognized. The increase in actuarial gain recognized is primarily due to changes in weighted-average discount rates in response to bond yields during the year. For the years ended December 31, 2024 and 2023, the changes in weighted-average discount rates were an increase of 42 basis points and a decrease of 34 basis points, respectively. </context> | us-gaap:DefinedBenefitPlanActuarialGainLoss |
For the years ended December 31, 2024 and 2023, postretirement benefits actuarial gains of $ 32 million and $ 7 million, respectively, were recognized. The increase in actuarial gain recognized is primarily due to changes in weighted-average discount rates in response to bond yields during the year. For the years ended December 31, 2024 and 2023, the changes in weighted-average discount rates were an increase of 42 basis points and a decrease of 34 basis points, respectively. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024 and 2023, postretirement benefits actuarial gains of $ 32 million and $ 7 million, respectively, were recognized. The increase in actuarial gain recognized is primarily due to changes in weighted-average discount rates in response to bond yields during the year. For the years ended December 31, 2024 and 2023, the changes in weighted-average discount rates were an increase of 42 basis points and a decrease of 34 basis points, respectively. </context> | us-gaap:DefinedBenefitPlanActuarialGainLoss |
The Company’s primary objective is to ensure the plan has sufficient return on assets to fund the plan’s current and future obligations as they become due. Investments are primarily made in public securities to ensure adequate liquidity to support benefit payments. Corning has a diversification to the portfolio through the investment in domestic stocks. The target allocation range equity investment is 50 % which includes large, mid and small-cap companies and investments in developed markets. The target allocation for bond investments is 50 %, which includes corporate bonds. Long-duration fixed income assets are utilized to mitigate the sensitivity of funding ratios to changes in interest rates. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> The Company’s primary objective is to ensure the plan has sufficient return on assets to fund the plan’s current and future obligations as they become due. Investments are primarily made in public securities to ensure adequate liquidity to support benefit payments. Corning has a diversification to the portfolio through the investment in domestic stocks. The target allocation range equity investment is 50 % which includes large, mid and small-cap companies and investments in developed markets. The target allocation for bond investments is 50 %, which includes corporate bonds. Long-duration fixed income assets are utilized to mitigate the sensitivity of funding ratios to changes in interest rates. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
41 % of domestic plan assets are invested in bonds with an average credit rating of AA-. These bonds are subject to both credit and default risk and changes in the risk could lead to a decline in the value of these bonds. | text | 41 | percentItemType | text: <entity> 41 </entity> <entity type> percentItemType </entity type> <context> 41 % of domestic plan assets are invested in bonds with an average credit rating of AA-. These bonds are subject to both credit and default risk and changes in the risk could lead to a decline in the value of these bonds. </context> | us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryPercentage |
Until June 1, 2016, Corning and The Dow Chemical Company (“Dow”) each owned 50 % of the common stock of Dow Corning Corporation (“Dow Corning”). On May 31, 2016, Corning and Dow realigned their ownership interest in Dow Corning. Following the realignment, Corning no longer owned any interest in Dow Corning. With the realignment, Corning agreed to indemnify Dow for 50 % of Dow Corning’s non-ordinary course, pre-closing liabilities to the extent such liabilities exceed the amounts reserved for them by Dow Corning as of May 31, 2016, subject to certain conditions and limits. In January 2024, we entered into an agreement to settle the Dow Corning Chapter 11 Related Matters and the settlement amount was not material. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> Until June 1, 2016, Corning and The Dow Chemical Company (“Dow”) each owned 50 % of the common stock of Dow Corning Corporation (“Dow Corning”). On May 31, 2016, Corning and Dow realigned their ownership interest in Dow Corning. Following the realignment, Corning no longer owned any interest in Dow Corning. With the realignment, Corning agreed to indemnify Dow for 50 % of Dow Corning’s non-ordinary course, pre-closing liabilities to the extent such liabilities exceed the amounts reserved for them by Dow Corning as of May 31, 2016, subject to certain conditions and limits. In January 2024, we entered into an agreement to settle the Dow Corning Chapter 11 Related Matters and the settlement amount was not material. </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
Corning has been designated by federal or state governments under environmental laws, including Superfund, as a potentially responsible party that may be liable for cleanup costs associated with 20 hazardous waste sites. It is Corning’s policy to accrue for its estimated liability related to such hazardous waste sites and other environmental liabilities related to property owned by Corning based on expert analysis and continual monitoring by both internal and external consultants. As of December 31, 2024 and 2023, Corning had accrued approximately $ 78 million and $ 88 million, respectively, for the estimated undiscounted liability for environmental cleanup and related litigation. Based upon the information developed to date, management believes that the accrued reserve is a reasonable estimate of the Company’s liability. | text | 78 | monetaryItemType | text: <entity> 78 </entity> <entity type> monetaryItemType </entity type> <context> Corning has been designated by federal or state governments under environmental laws, including Superfund, as a potentially responsible party that may be liable for cleanup costs associated with 20 hazardous waste sites. It is Corning’s policy to accrue for its estimated liability related to such hazardous waste sites and other environmental liabilities related to property owned by Corning based on expert analysis and continual monitoring by both internal and external consultants. As of December 31, 2024 and 2023, Corning had accrued approximately $ 78 million and $ 88 million, respectively, for the estimated undiscounted liability for environmental cleanup and related litigation. Based upon the information developed to date, management believes that the accrued reserve is a reasonable estimate of the Company’s liability. </context> | us-gaap:AccrualForEnvironmentalLossContingencies |
Corning has been designated by federal or state governments under environmental laws, including Superfund, as a potentially responsible party that may be liable for cleanup costs associated with 20 hazardous waste sites. It is Corning’s policy to accrue for its estimated liability related to such hazardous waste sites and other environmental liabilities related to property owned by Corning based on expert analysis and continual monitoring by both internal and external consultants. As of December 31, 2024 and 2023, Corning had accrued approximately $ 78 million and $ 88 million, respectively, for the estimated undiscounted liability for environmental cleanup and related litigation. Based upon the information developed to date, management believes that the accrued reserve is a reasonable estimate of the Company’s liability. | text | 88 | monetaryItemType | text: <entity> 88 </entity> <entity type> monetaryItemType </entity type> <context> Corning has been designated by federal or state governments under environmental laws, including Superfund, as a potentially responsible party that may be liable for cleanup costs associated with 20 hazardous waste sites. It is Corning’s policy to accrue for its estimated liability related to such hazardous waste sites and other environmental liabilities related to property owned by Corning based on expert analysis and continual monitoring by both internal and external consultants. As of December 31, 2024 and 2023, Corning had accrued approximately $ 78 million and $ 88 million, respectively, for the estimated undiscounted liability for environmental cleanup and related litigation. Based upon the information developed to date, management believes that the accrued reserve is a reasonable estimate of the Company’s liability. </context> | us-gaap:AccrualForEnvironmentalLossContingencies |
As of December 31, 2024, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 928 million and fair value hedges of leased precious metals with a gross notional amount of 12,694 troy ounces. As of December 31, 2023, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 241 million and fair value hedges of leased precious metals with a gross notional amount of 20,160 troy ounces. Fair value assets include designated derivatives pertaining to precious metals lease contracts in the amounts of $ 104 million and $ 229 million as of December 31, 2024 and 2023, respectively. | text | 928 | monetaryItemType | text: <entity> 928 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 928 million and fair value hedges of leased precious metals with a gross notional amount of 12,694 troy ounces. As of December 31, 2023, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 241 million and fair value hedges of leased precious metals with a gross notional amount of 20,160 troy ounces. Fair value assets include designated derivatives pertaining to precious metals lease contracts in the amounts of $ 104 million and $ 229 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DerivativeNotionalAmount |
As of December 31, 2024, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 928 million and fair value hedges of leased precious metals with a gross notional amount of 12,694 troy ounces. As of December 31, 2023, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 241 million and fair value hedges of leased precious metals with a gross notional amount of 20,160 troy ounces. Fair value assets include designated derivatives pertaining to precious metals lease contracts in the amounts of $ 104 million and $ 229 million as of December 31, 2024 and 2023, respectively. | text | 241 | monetaryItemType | text: <entity> 241 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 928 million and fair value hedges of leased precious metals with a gross notional amount of 12,694 troy ounces. As of December 31, 2023, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 241 million and fair value hedges of leased precious metals with a gross notional amount of 20,160 troy ounces. Fair value assets include designated derivatives pertaining to precious metals lease contracts in the amounts of $ 104 million and $ 229 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DerivativeNotionalAmount |
As of December 31, 2024, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 928 million and fair value hedges of leased precious metals with a gross notional amount of 12,694 troy ounces. As of December 31, 2023, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 241 million and fair value hedges of leased precious metals with a gross notional amount of 20,160 troy ounces. Fair value assets include designated derivatives pertaining to precious metals lease contracts in the amounts of $ 104 million and $ 229 million as of December 31, 2024 and 2023, respectively. | text | 104 | monetaryItemType | text: <entity> 104 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 928 million and fair value hedges of leased precious metals with a gross notional amount of 12,694 troy ounces. As of December 31, 2023, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 241 million and fair value hedges of leased precious metals with a gross notional amount of 20,160 troy ounces. Fair value assets include designated derivatives pertaining to precious metals lease contracts in the amounts of $ 104 million and $ 229 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DerivativeNotionalAmount |
As of December 31, 2024, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 928 million and fair value hedges of leased precious metals with a gross notional amount of 12,694 troy ounces. As of December 31, 2023, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 241 million and fair value hedges of leased precious metals with a gross notional amount of 20,160 troy ounces. Fair value assets include designated derivatives pertaining to precious metals lease contracts in the amounts of $ 104 million and $ 229 million as of December 31, 2024 and 2023, respectively. | text | 229 | monetaryItemType | text: <entity> 229 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 928 million and fair value hedges of leased precious metals with a gross notional amount of 12,694 troy ounces. As of December 31, 2023, derivatives designated as hedging instruments include foreign exchange cash flow hedges with gross notional amounts of $ 241 million and fair value hedges of leased precious metals with a gross notional amount of 20,160 troy ounces. Fair value assets include designated derivatives pertaining to precious metals lease contracts in the amounts of $ 104 million and $ 229 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DerivativeNotionalAmount |
The following tables summarize the effect in the consolidated statements of income relating to Corning’s derivative financial instruments (in millions). The accumulated derivative (loss) gain included in accumulated other comprehensive loss on the consolidated balance sheets as of December 31, 2024 and 2023 is $( 11 ) million and $ 54 million, respectively. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> The following tables summarize the effect in the consolidated statements of income relating to Corning’s derivative financial instruments (in millions). The accumulated derivative (loss) gain included in accumulated other comprehensive loss on the consolidated balance sheets as of December 31, 2024 and 2023 is $( 11 ) million and $ 54 million, respectively. </context> | us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax |
The following tables summarize the effect in the consolidated statements of income relating to Corning’s derivative financial instruments (in millions). The accumulated derivative (loss) gain included in accumulated other comprehensive loss on the consolidated balance sheets as of December 31, 2024 and 2023 is $( 11 ) million and $ 54 million, respectively. | text | 54 | monetaryItemType | text: <entity> 54 </entity> <entity type> monetaryItemType </entity type> <context> The following tables summarize the effect in the consolidated statements of income relating to Corning’s derivative financial instruments (in millions). The accumulated derivative (loss) gain included in accumulated other comprehensive loss on the consolidated balance sheets as of December 31, 2024 and 2023 is $( 11 ) million and $ 54 million, respectively. </context> | us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax |
counterparties, representing an exchange of the notional amounts at a fixed foreign exchange rate of Japanese yen to U.S. dollar and was initially recorded as a derivative liability. The net payments received were $ 134 million and as of December 31, 2024, the fair value of this derivative liability is $ 148 million. | text | 134 | monetaryItemType | text: <entity> 134 </entity> <entity type> monetaryItemType </entity type> <context> counterparties, representing an exchange of the notional amounts at a fixed foreign exchange rate of Japanese yen to U.S. dollar and was initially recorded as a derivative liability. The net payments received were $ 134 million and as of December 31, 2024, the fair value of this derivative liability is $ 148 million. </context> | us-gaap:DerivativeCashReceivedOnHedge |
counterparties, representing an exchange of the notional amounts at a fixed foreign exchange rate of Japanese yen to U.S. dollar and was initially recorded as a derivative liability. The net payments received were $ 134 million and as of December 31, 2024, the fair value of this derivative liability is $ 148 million. | text | 148 | monetaryItemType | text: <entity> 148 </entity> <entity type> monetaryItemType </entity type> <context> counterparties, representing an exchange of the notional amounts at a fixed foreign exchange rate of Japanese yen to U.S. dollar and was initially recorded as a derivative liability. The net payments received were $ 134 million and as of December 31, 2024, the fair value of this derivative liability is $ 148 million. </context> | us-gaap:DerivativeFairValueOfDerivativeNet |
In May 2023, Corning designated the full amount of its euro-denominated 2026 Notes and 2031 Notes with a total notional amount of € 850 million, which are non-derivative financial instruments, as net investment hedges against our investments in certain European subsidiaries with euro functional currencies. As of December 31, 2024, the net investment hedges are deemed to be effective. During the years ended December 31, 2024 and 2023, foreign currency gains of $ 55 million and foreign currency losses of $ 5 million, respectively, associated with these net investment hedges were recognized in other comprehensive income. | text | 850 | monetaryItemType | text: <entity> 850 </entity> <entity type> monetaryItemType </entity type> <context> In May 2023, Corning designated the full amount of its euro-denominated 2026 Notes and 2031 Notes with a total notional amount of € 850 million, which are non-derivative financial instruments, as net investment hedges against our investments in certain European subsidiaries with euro functional currencies. As of December 31, 2024, the net investment hedges are deemed to be effective. During the years ended December 31, 2024 and 2023, foreign currency gains of $ 55 million and foreign currency losses of $ 5 million, respectively, associated with these net investment hedges were recognized in other comprehensive income. </context> | us-gaap:NotionalAmountOfNonderivativeInstruments |
In May 2023, Corning designated the full amount of its euro-denominated 2026 Notes and 2031 Notes with a total notional amount of € 850 million, which are non-derivative financial instruments, as net investment hedges against our investments in certain European subsidiaries with euro functional currencies. As of December 31, 2024, the net investment hedges are deemed to be effective. During the years ended December 31, 2024 and 2023, foreign currency gains of $ 55 million and foreign currency losses of $ 5 million, respectively, associated with these net investment hedges were recognized in other comprehensive income. | text | 55 | monetaryItemType | text: <entity> 55 </entity> <entity type> monetaryItemType </entity type> <context> In May 2023, Corning designated the full amount of its euro-denominated 2026 Notes and 2031 Notes with a total notional amount of € 850 million, which are non-derivative financial instruments, as net investment hedges against our investments in certain European subsidiaries with euro functional currencies. As of December 31, 2024, the net investment hedges are deemed to be effective. During the years ended December 31, 2024 and 2023, foreign currency gains of $ 55 million and foreign currency losses of $ 5 million, respectively, associated with these net investment hedges were recognized in other comprehensive income. </context> | us-gaap:ForeignCurrencyTransactionGainBeforeTax |
In May 2023, Corning designated the full amount of its euro-denominated 2026 Notes and 2031 Notes with a total notional amount of € 850 million, which are non-derivative financial instruments, as net investment hedges against our investments in certain European subsidiaries with euro functional currencies. As of December 31, 2024, the net investment hedges are deemed to be effective. During the years ended December 31, 2024 and 2023, foreign currency gains of $ 55 million and foreign currency losses of $ 5 million, respectively, associated with these net investment hedges were recognized in other comprehensive income. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> In May 2023, Corning designated the full amount of its euro-denominated 2026 Notes and 2031 Notes with a total notional amount of € 850 million, which are non-derivative financial instruments, as net investment hedges against our investments in certain European subsidiaries with euro functional currencies. As of December 31, 2024, the net investment hedges are deemed to be effective. During the years ended December 31, 2024 and 2023, foreign currency gains of $ 55 million and foreign currency losses of $ 5 million, respectively, associated with these net investment hedges were recognized in other comprehensive income. </context> | us-gaap:ForeignCurrencyTransactionLossBeforeTax |
The carrying amount of the leased precious metals pool, which is included within property, plant and equipment, net of accumulated depreciation in the consolidated balance sheets, is $ 58 million and $ 90 million, respectively, as of December 31, 2024 and 2023. The carrying amount of the leased precious metals pool includes cumulative fair value loss of $ 108 million and $ 239 million as of December 31, 2024 and 2023, respectively. These losses are offset by changes in the fair value of the hedges. | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> The carrying amount of the leased precious metals pool, which is included within property, plant and equipment, net of accumulated depreciation in the consolidated balance sheets, is $ 58 million and $ 90 million, respectively, as of December 31, 2024 and 2023. The carrying amount of the leased precious metals pool includes cumulative fair value loss of $ 108 million and $ 239 million as of December 31, 2024 and 2023, respectively. These losses are offset by changes in the fair value of the hedges. </context> | us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue |
The carrying amount of the leased precious metals pool, which is included within property, plant and equipment, net of accumulated depreciation in the consolidated balance sheets, is $ 58 million and $ 90 million, respectively, as of December 31, 2024 and 2023. The carrying amount of the leased precious metals pool includes cumulative fair value loss of $ 108 million and $ 239 million as of December 31, 2024 and 2023, respectively. These losses are offset by changes in the fair value of the hedges. | text | 90 | monetaryItemType | text: <entity> 90 </entity> <entity type> monetaryItemType </entity type> <context> The carrying amount of the leased precious metals pool, which is included within property, plant and equipment, net of accumulated depreciation in the consolidated balance sheets, is $ 58 million and $ 90 million, respectively, as of December 31, 2024 and 2023. The carrying amount of the leased precious metals pool includes cumulative fair value loss of $ 108 million and $ 239 million as of December 31, 2024 and 2023, respectively. These losses are offset by changes in the fair value of the hedges. </context> | us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue |
The carrying amount of the leased precious metals pool, which is included within property, plant and equipment, net of accumulated depreciation in the consolidated balance sheets, is $ 58 million and $ 90 million, respectively, as of December 31, 2024 and 2023. The carrying amount of the leased precious metals pool includes cumulative fair value loss of $ 108 million and $ 239 million as of December 31, 2024 and 2023, respectively. These losses are offset by changes in the fair value of the hedges. | text | 108 | monetaryItemType | text: <entity> 108 </entity> <entity type> monetaryItemType </entity type> <context> The carrying amount of the leased precious metals pool, which is included within property, plant and equipment, net of accumulated depreciation in the consolidated balance sheets, is $ 58 million and $ 90 million, respectively, as of December 31, 2024 and 2023. The carrying amount of the leased precious metals pool includes cumulative fair value loss of $ 108 million and $ 239 million as of December 31, 2024 and 2023, respectively. These losses are offset by changes in the fair value of the hedges. </context> | us-gaap:HedgedAssetFairValueHedgeCumulativeIncreaseDecrease |
The carrying amount of the leased precious metals pool, which is included within property, plant and equipment, net of accumulated depreciation in the consolidated balance sheets, is $ 58 million and $ 90 million, respectively, as of December 31, 2024 and 2023. The carrying amount of the leased precious metals pool includes cumulative fair value loss of $ 108 million and $ 239 million as of December 31, 2024 and 2023, respectively. These losses are offset by changes in the fair value of the hedges. | text | 239 | monetaryItemType | text: <entity> 239 </entity> <entity type> monetaryItemType </entity type> <context> The carrying amount of the leased precious metals pool, which is included within property, plant and equipment, net of accumulated depreciation in the consolidated balance sheets, is $ 58 million and $ 90 million, respectively, as of December 31, 2024 and 2023. The carrying amount of the leased precious metals pool includes cumulative fair value loss of $ 108 million and $ 239 million as of December 31, 2024 and 2023, respectively. These losses are offset by changes in the fair value of the hedges. </context> | us-gaap:HedgedAssetFairValueHedgeCumulativeIncreaseDecrease |
On February 12, 2025, Corning’s Board of Directors declared a quarterly dividend of $ 0.28 per share common stock, which will be payable on March 28, 2025. | text | 0.28 | perShareItemType | text: <entity> 0.28 </entity> <entity type> perShareItemType </entity type> <context> On February 12, 2025, Corning’s Board of Directors declared a quarterly dividend of $ 0.28 per share common stock, which will be payable on March 28, 2025. </context> | us-gaap:CommonStockDividendsPerShareDeclared |
The Company had 2,300 outstanding shares of Fixed Rate Cumulative Convertible Preferred Stock, Series A (the “Preferred Stock”) as of December 31, 2020. On January 16, 2021, the Preferred Stock became convertible into 115 million common shares. On April 5, 2021 Corning and Samsung Display Co., Ltd. (“SDC”) executed the Share Repurchase Agreement (“SRA”), and the Preferred Stock was fully converted as of April 8, 2021. Immediately following the conversion, Corning repurchased and retired 35 million of the common shares held by SDC for an aggregate purchase price of approximately $ 1.5 billion, of which approximately $ 507 million was paid in April in each of 2023, 2022 and 2021. | text | 2300 | sharesItemType | text: <entity> 2300 </entity> <entity type> sharesItemType </entity type> <context> The Company had 2,300 outstanding shares of Fixed Rate Cumulative Convertible Preferred Stock, Series A (the “Preferred Stock”) as of December 31, 2020. On January 16, 2021, the Preferred Stock became convertible into 115 million common shares. On April 5, 2021 Corning and Samsung Display Co., Ltd. (“SDC”) executed the Share Repurchase Agreement (“SRA”), and the Preferred Stock was fully converted as of April 8, 2021. Immediately following the conversion, Corning repurchased and retired 35 million of the common shares held by SDC for an aggregate purchase price of approximately $ 1.5 billion, of which approximately $ 507 million was paid in April in each of 2023, 2022 and 2021. </context> | us-gaap:PreferredStockSharesOutstanding |
The Company had 2,300 outstanding shares of Fixed Rate Cumulative Convertible Preferred Stock, Series A (the “Preferred Stock”) as of December 31, 2020. On January 16, 2021, the Preferred Stock became convertible into 115 million common shares. On April 5, 2021 Corning and Samsung Display Co., Ltd. (“SDC”) executed the Share Repurchase Agreement (“SRA”), and the Preferred Stock was fully converted as of April 8, 2021. Immediately following the conversion, Corning repurchased and retired 35 million of the common shares held by SDC for an aggregate purchase price of approximately $ 1.5 billion, of which approximately $ 507 million was paid in April in each of 2023, 2022 and 2021. | text | 115 | sharesItemType | text: <entity> 115 </entity> <entity type> sharesItemType </entity type> <context> The Company had 2,300 outstanding shares of Fixed Rate Cumulative Convertible Preferred Stock, Series A (the “Preferred Stock”) as of December 31, 2020. On January 16, 2021, the Preferred Stock became convertible into 115 million common shares. On April 5, 2021 Corning and Samsung Display Co., Ltd. (“SDC”) executed the Share Repurchase Agreement (“SRA”), and the Preferred Stock was fully converted as of April 8, 2021. Immediately following the conversion, Corning repurchased and retired 35 million of the common shares held by SDC for an aggregate purchase price of approximately $ 1.5 billion, of which approximately $ 507 million was paid in April in each of 2023, 2022 and 2021. </context> | us-gaap:PreferredStockConvertibleSharesIssuable |
The Company had 2,300 outstanding shares of Fixed Rate Cumulative Convertible Preferred Stock, Series A (the “Preferred Stock”) as of December 31, 2020. On January 16, 2021, the Preferred Stock became convertible into 115 million common shares. On April 5, 2021 Corning and Samsung Display Co., Ltd. (“SDC”) executed the Share Repurchase Agreement (“SRA”), and the Preferred Stock was fully converted as of April 8, 2021. Immediately following the conversion, Corning repurchased and retired 35 million of the common shares held by SDC for an aggregate purchase price of approximately $ 1.5 billion, of which approximately $ 507 million was paid in April in each of 2023, 2022 and 2021. | text | 35 | sharesItemType | text: <entity> 35 </entity> <entity type> sharesItemType </entity type> <context> The Company had 2,300 outstanding shares of Fixed Rate Cumulative Convertible Preferred Stock, Series A (the “Preferred Stock”) as of December 31, 2020. On January 16, 2021, the Preferred Stock became convertible into 115 million common shares. On April 5, 2021 Corning and Samsung Display Co., Ltd. (“SDC”) executed the Share Repurchase Agreement (“SRA”), and the Preferred Stock was fully converted as of April 8, 2021. Immediately following the conversion, Corning repurchased and retired 35 million of the common shares held by SDC for an aggregate purchase price of approximately $ 1.5 billion, of which approximately $ 507 million was paid in April in each of 2023, 2022 and 2021. </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
The Company had 2,300 outstanding shares of Fixed Rate Cumulative Convertible Preferred Stock, Series A (the “Preferred Stock”) as of December 31, 2020. On January 16, 2021, the Preferred Stock became convertible into 115 million common shares. On April 5, 2021 Corning and Samsung Display Co., Ltd. (“SDC”) executed the Share Repurchase Agreement (“SRA”), and the Preferred Stock was fully converted as of April 8, 2021. Immediately following the conversion, Corning repurchased and retired 35 million of the common shares held by SDC for an aggregate purchase price of approximately $ 1.5 billion, of which approximately $ 507 million was paid in April in each of 2023, 2022 and 2021. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company had 2,300 outstanding shares of Fixed Rate Cumulative Convertible Preferred Stock, Series A (the “Preferred Stock”) as of December 31, 2020. On January 16, 2021, the Preferred Stock became convertible into 115 million common shares. On April 5, 2021 Corning and Samsung Display Co., Ltd. (“SDC”) executed the Share Repurchase Agreement (“SRA”), and the Preferred Stock was fully converted as of April 8, 2021. Immediately following the conversion, Corning repurchased and retired 35 million of the common shares held by SDC for an aggregate purchase price of approximately $ 1.5 billion, of which approximately $ 507 million was paid in April in each of 2023, 2022 and 2021. </context> | us-gaap:PaymentsForRepurchaseOfCommonStock |
Pursuant to the SRA, with respect to the remaining 80 million common shares outstanding held by SDC, 58 million shares are subject to a seven-year lock-up period expiring in 2027. The remaining 22 million common shares can be offered to be sold to Corning in specified tranches from time to time in calendar years 2024 through 2027. Corning may, at its sole discretion, elect to repurchase such common shares. If Corning elects not to repurchase the common shares and SDC sells the common shares on the open market, Corning is required to pay SDC a make-whole payment, subject to a 5 % cap of the repurchase proceeds that otherwise would have been paid by Corning. As of December 31, 2024, 2023 and 2022, the fair value of the liability associated with this option, measured using Level 2 significant other observable inputs, was not material. | text | 80 | sharesItemType | text: <entity> 80 </entity> <entity type> sharesItemType </entity type> <context> Pursuant to the SRA, with respect to the remaining 80 million common shares outstanding held by SDC, 58 million shares are subject to a seven-year lock-up period expiring in 2027. The remaining 22 million common shares can be offered to be sold to Corning in specified tranches from time to time in calendar years 2024 through 2027. Corning may, at its sole discretion, elect to repurchase such common shares. If Corning elects not to repurchase the common shares and SDC sells the common shares on the open market, Corning is required to pay SDC a make-whole payment, subject to a 5 % cap of the repurchase proceeds that otherwise would have been paid by Corning. As of December 31, 2024, 2023 and 2022, the fair value of the liability associated with this option, measured using Level 2 significant other observable inputs, was not material. </context> | us-gaap:CommonStockSharesOutstanding |
Pursuant to the SRA, with respect to the remaining 80 million common shares outstanding held by SDC, 58 million shares are subject to a seven-year lock-up period expiring in 2027. The remaining 22 million common shares can be offered to be sold to Corning in specified tranches from time to time in calendar years 2024 through 2027. Corning may, at its sole discretion, elect to repurchase such common shares. If Corning elects not to repurchase the common shares and SDC sells the common shares on the open market, Corning is required to pay SDC a make-whole payment, subject to a 5 % cap of the repurchase proceeds that otherwise would have been paid by Corning. As of December 31, 2024, 2023 and 2022, the fair value of the liability associated with this option, measured using Level 2 significant other observable inputs, was not material. | text | 22 | sharesItemType | text: <entity> 22 </entity> <entity type> sharesItemType </entity type> <context> Pursuant to the SRA, with respect to the remaining 80 million common shares outstanding held by SDC, 58 million shares are subject to a seven-year lock-up period expiring in 2027. The remaining 22 million common shares can be offered to be sold to Corning in specified tranches from time to time in calendar years 2024 through 2027. Corning may, at its sole discretion, elect to repurchase such common shares. If Corning elects not to repurchase the common shares and SDC sells the common shares on the open market, Corning is required to pay SDC a make-whole payment, subject to a 5 % cap of the repurchase proceeds that otherwise would have been paid by Corning. As of December 31, 2024, 2023 and 2022, the fair value of the liability associated with this option, measured using Level 2 significant other observable inputs, was not material. </context> | us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased |
In 2019, the Board authorized the repurchase of up to $ 5.0 billion of additional common stock (“2019 Authorization”), which does not have an expiration date and may be amended or terminated by the Board of Directors at any time without prior notice. As of December 31, 2024, approximately $ 3.1 billion remains available under the Company’s 2019 Authorization. | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> In 2019, the Board authorized the repurchase of up to $ 5.0 billion of additional common stock (“2019 Authorization”), which does not have an expiration date and may be amended or terminated by the Board of Directors at any time without prior notice. As of December 31, 2024, approximately $ 3.1 billion remains available under the Company’s 2019 Authorization. </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. | text | 4.4 | sharesItemType | text: <entity> 4.4 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. | text | 6.0 | sharesItemType | text: <entity> 6.0 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. | text | 165 | monetaryItemType | text: <entity> 165 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. </context> | us-gaap:PaymentsForRepurchaseOfCommonStock |
During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. | text | 221 | monetaryItemType | text: <entity> 221 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. </context> | us-gaap:PaymentsForRepurchaseOfCommonStock |
During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. | text | No | sharesItemType | text: <entity> No </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024 and 2022, the Company repurchased 4.4 million and 6.0 million shares of common stock for approximately $ 165 million and $ 221 million, respectively. No shares were repurchased during the year ended December 31, 2023. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
Amounts are net of total tax benefit of $ 22 million, primarily driven by $ 29 million and $ 24 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 31 million related to retirement plans. | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 22 million, primarily driven by $ 29 million and $ 24 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 31 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 22 million, primarily driven by $ 29 million and $ 24 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 31 million related to retirement plans. | text | 29 | monetaryItemType | text: <entity> 29 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 22 million, primarily driven by $ 29 million and $ 24 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 31 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 22 million, primarily driven by $ 29 million and $ 24 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 31 million related to retirement plans. | text | 24 | monetaryItemType | text: <entity> 24 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 22 million, primarily driven by $ 29 million and $ 24 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 31 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 22 million, primarily driven by $ 29 million and $ 24 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 31 million related to retirement plans. | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 22 million, primarily driven by $ 29 million and $ 24 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 31 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 19 million, primarily driven by $ 12 million and $ 8 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 1 million related to retirement plans. | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 19 million, primarily driven by $ 12 million and $ 8 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 1 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 19 million, primarily driven by $ 12 million and $ 8 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 1 million related to retirement plans. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 19 million, primarily driven by $ 12 million and $ 8 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 1 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 19 million, primarily driven by $ 12 million and $ 8 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 1 million related to retirement plans. | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 19 million, primarily driven by $ 12 million and $ 8 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 1 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 19 million, primarily driven by $ 12 million and $ 8 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 1 million related to retirement plans. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 19 million, primarily driven by $ 12 million and $ 8 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 1 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 21 million, primarily driven by $ 50 million and $ 29 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 58 million related to retirement plans. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 21 million, primarily driven by $ 50 million and $ 29 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 58 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 21 million, primarily driven by $ 50 million and $ 29 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 58 million related to retirement plans. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 21 million, primarily driven by $ 50 million and $ 29 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 58 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 21 million, primarily driven by $ 50 million and $ 29 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 58 million related to retirement plans. | text | 29 | monetaryItemType | text: <entity> 29 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 21 million, primarily driven by $ 50 million and $ 29 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 58 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Amounts are net of total tax benefit of $ 21 million, primarily driven by $ 50 million and $ 29 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 58 million related to retirement plans. | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> Amounts are net of total tax benefit of $ 21 million, primarily driven by $ 50 million and $ 29 million related to foreign currency translation adjustments and the hedging component, respectively, offset by negative impacts of $ 58 million related to retirement plans. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
The income tax benefit realized from share-based compensation was $ 9 million, $ 17 million and $ 16 million, respectively, for the years ended December 31, 2024, 2023 and 2022. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> The income tax benefit realized from share-based compensation was $ 9 million, $ 17 million and $ 16 million, respectively, for the years ended December 31, 2024, 2023 and 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The income tax benefit realized from share-based compensation was $ 9 million, $ 17 million and $ 16 million, respectively, for the years ended December 31, 2024, 2023 and 2022. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> The income tax benefit realized from share-based compensation was $ 9 million, $ 17 million and $ 16 million, respectively, for the years ended December 31, 2024, 2023 and 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The income tax benefit realized from share-based compensation was $ 9 million, $ 17 million and $ 16 million, respectively, for the years ended December 31, 2024, 2023 and 2022. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> The income tax benefit realized from share-based compensation was $ 9 million, $ 17 million and $ 16 million, respectively, for the years ended December 31, 2024, 2023 and 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
As of December 31, 2024, there were approximately 19 million unissued common shares available for future grants authorized under the Plans. | text | 19 | sharesItemType | text: <entity> 19 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there were approximately 19 million unissued common shares available for future grants authorized under the Plans. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The total fair value of time-based restricted stock and restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 208 million, $ 118 million and $ 93 million, respectively. | text | 208 | monetaryItemType | text: <entity> 208 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of time-based restricted stock and restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 208 million, $ 118 million and $ 93 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of time-based restricted stock and restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 208 million, $ 118 million and $ 93 million, respectively. | text | 118 | monetaryItemType | text: <entity> 118 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of time-based restricted stock and restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 208 million, $ 118 million and $ 93 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of time-based restricted stock and restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 208 million, $ 118 million and $ 93 million, respectively. | text | 93 | monetaryItemType | text: <entity> 93 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of time-based restricted stock and restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 208 million, $ 118 million and $ 93 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of performance-based restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 47 million, $ 120 million and $ 5 million, respectively. | text | 47 | monetaryItemType | text: <entity> 47 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of performance-based restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 47 million, $ 120 million and $ 5 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of performance-based restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 47 million, $ 120 million and $ 5 million, respectively. | text | 120 | monetaryItemType | text: <entity> 120 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of performance-based restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 47 million, $ 120 million and $ 5 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of performance-based restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 47 million, $ 120 million and $ 5 million, respectively. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of performance-based restricted stock units that vested during the years ended December 31, 2024, 2023 and 2022 was approximately $ 47 million, $ 120 million and $ 5 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . | text | 3.3 | sharesItemType | text: <entity> 3.3 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . </context> | us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised |
During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . | text | 9 | sharesItemType | text: <entity> 9 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod |
During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . | text | 23.37 | perShareItemType | text: <entity> 23.37 </entity> <entity type> perShareItemType </entity type> <context> During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . </context> | us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice |
During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . | text | 19.97 | perShareItemType | text: <entity> 19.97 </entity> <entity type> perShareItemType </entity type> <context> During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue |
During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . | text | 4.2 | sharesItemType | text: <entity> 4.2 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber |
During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . | text | 24.18 | perShareItemType | text: <entity> 24.18 </entity> <entity type> perShareItemType </entity type> <context> During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . | text | 99 | monetaryItemType | text: <entity> 99 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue |
During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . | text | 7.5 | sharesItemType | text: <entity> 7.5 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, 3.3 million options were exercised and 9 thousand options were forfeited and expired with a weighted-average exercise price of $ 23.37 and $ 19.97 , respectively. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 24.18 , weighted average remaining contractual term of 4.2 years and aggregate intrinsic value of $ 99 million. As of December 31, 2023, 7.5 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $ 23.82 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber |
There were no options granted in 2024, 2023 or 2022. The total fair value of options that vested during the years ended December 31, 2023 and 2022 was approximately $ 6 million and $ 20 million, respectively. There were no options that vested during the year ended December 31, 2024. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> There were no options granted in 2024, 2023 or 2022. The total fair value of options that vested during the years ended December 31, 2023 and 2022 was approximately $ 6 million and $ 20 million, respectively. There were no options that vested during the year ended December 31, 2024. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
There were no options granted in 2024, 2023 or 2022. The total fair value of options that vested during the years ended December 31, 2023 and 2022 was approximately $ 6 million and $ 20 million, respectively. There were no options that vested during the year ended December 31, 2024. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> There were no options granted in 2024, 2023 or 2022. The total fair value of options that vested during the years ended December 31, 2023 and 2022 was approximately $ 6 million and $ 20 million, respectively. There were no options that vested during the year ended December 31, 2024. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. | text | 76 | monetaryItemType | text: <entity> 76 </entity> <entity type> monetaryItemType </entity type> <context> Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. </context> | us-gaap:ProceedsFromStockOptionsExercised |
Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. | text | 56 | monetaryItemType | text: <entity> 56 </entity> <entity type> monetaryItemType </entity type> <context> Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. | text | 29 | monetaryItemType | text: <entity> 29 </entity> <entity type> monetaryItemType </entity type> <context> Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. | text | 36 | monetaryItemType | text: <entity> 36 </entity> <entity type> monetaryItemType </entity type> <context> Proceeds received from the exercise of stock options were $ 76 million, with a corresponding realized tax benefit of $ 8 million, for the year ended December 31, 2024. The total intrinsic value of options exercised for the years ended December 31, 2024, 2023 and 2022 was approximately $ 56 million, $ 29 million and $ 36 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (“GE”), completed the spin-off of GE HealthCare Technologies Inc. (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1 % of the Company’s outstanding common stock to holders of record of GE’s common stock as of the close of business on December 16, 2022 (the “Distribution”), which resulted in the issuance of approximately 454 million shares of common stock. Prior to the Distribution, the Company issued 100 shares of common stock in exchange for $ 1.00 , all of which were held by GE as of December 31, 2022. As a result of the Distribution, the Company became an independent public company. On April 2, 2024, GE completed the separation of its GE Vernova business into an independent publicly traded company. In the fourth quarter of 2024, GE sold its remaining ownership of the Company’s outstanding common stock. Following the share sell-down, GE continues to be reported as a related party due to the nature of our relationship and board member affiliation. | text | 454 | sharesItemType | text: <entity> 454 </entity> <entity type> sharesItemType </entity type> <context> On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (“GE”), completed the spin-off of GE HealthCare Technologies Inc. (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1 % of the Company’s outstanding common stock to holders of record of GE’s common stock as of the close of business on December 16, 2022 (the “Distribution”), which resulted in the issuance of approximately 454 million shares of common stock. Prior to the Distribution, the Company issued 100 shares of common stock in exchange for $ 1.00 , all of which were held by GE as of December 31, 2022. As a result of the Distribution, the Company became an independent public company. On April 2, 2024, GE completed the separation of its GE Vernova business into an independent publicly traded company. In the fourth quarter of 2024, GE sold its remaining ownership of the Company’s outstanding common stock. Following the share sell-down, GE continues to be reported as a related party due to the nature of our relationship and board member affiliation. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (“GE”), completed the spin-off of GE HealthCare Technologies Inc. (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1 % of the Company’s outstanding common stock to holders of record of GE’s common stock as of the close of business on December 16, 2022 (the “Distribution”), which resulted in the issuance of approximately 454 million shares of common stock. Prior to the Distribution, the Company issued 100 shares of common stock in exchange for $ 1.00 , all of which were held by GE as of December 31, 2022. As a result of the Distribution, the Company became an independent public company. On April 2, 2024, GE completed the separation of its GE Vernova business into an independent publicly traded company. In the fourth quarter of 2024, GE sold its remaining ownership of the Company’s outstanding common stock. Following the share sell-down, GE continues to be reported as a related party due to the nature of our relationship and board member affiliation. | text | 100 | sharesItemType | text: <entity> 100 </entity> <entity type> sharesItemType </entity type> <context> On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (“GE”), completed the spin-off of GE HealthCare Technologies Inc. (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1 % of the Company’s outstanding common stock to holders of record of GE’s common stock as of the close of business on December 16, 2022 (the “Distribution”), which resulted in the issuance of approximately 454 million shares of common stock. Prior to the Distribution, the Company issued 100 shares of common stock in exchange for $ 1.00 , all of which were held by GE as of December 31, 2022. As a result of the Distribution, the Company became an independent public company. On April 2, 2024, GE completed the separation of its GE Vernova business into an independent publicly traded company. In the fourth quarter of 2024, GE sold its remaining ownership of the Company’s outstanding common stock. Following the share sell-down, GE continues to be reported as a related party due to the nature of our relationship and board member affiliation. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (“GE”), completed the spin-off of GE HealthCare Technologies Inc. (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1 % of the Company’s outstanding common stock to holders of record of GE’s common stock as of the close of business on December 16, 2022 (the “Distribution”), which resulted in the issuance of approximately 454 million shares of common stock. Prior to the Distribution, the Company issued 100 shares of common stock in exchange for $ 1.00 , all of which were held by GE as of December 31, 2022. As a result of the Distribution, the Company became an independent public company. On April 2, 2024, GE completed the separation of its GE Vernova business into an independent publicly traded company. In the fourth quarter of 2024, GE sold its remaining ownership of the Company’s outstanding common stock. Following the share sell-down, GE continues to be reported as a related party due to the nature of our relationship and board member affiliation. | text | 1.00 | perShareItemType | text: <entity> 1.00 </entity> <entity type> perShareItemType </entity type> <context> On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (“GE”), completed the spin-off of GE HealthCare Technologies Inc. (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1 % of the Company’s outstanding common stock to holders of record of GE’s common stock as of the close of business on December 16, 2022 (the “Distribution”), which resulted in the issuance of approximately 454 million shares of common stock. Prior to the Distribution, the Company issued 100 shares of common stock in exchange for $ 1.00 , all of which were held by GE as of December 31, 2022. As a result of the Distribution, the Company became an independent public company. On April 2, 2024, GE completed the separation of its GE Vernova business into an independent publicly traded company. In the fourth quarter of 2024, GE sold its remaining ownership of the Company’s outstanding common stock. Following the share sell-down, GE continues to be reported as a related party due to the nature of our relationship and board member affiliation. </context> | us-gaap:SaleOfStockPricePerShare |
Publicly traded equity securities for which we do not have the ability to exercise significant influence are recorded at fair value with changes in fair value recognized in Other (income) expense – net in the Consolidated and Combined Statements of Income. Privately held equity securities for which we do not have the ability to exercise significant influence are accounted for using the measurement alternative approach and are recorded at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, with changes in the measurement recognized through Other (income) expense – net in the Consolidated and Combined Statements of Income. Equity investments without readily determinable fair value as of December 31, 2024 and 2023 were $ 176 million and $ 156 million, respectively. Investment securities are recognized within All other non-current assets in the Consolidated Statements of Financial Position. | text | 176 | monetaryItemType | text: <entity> 176 </entity> <entity type> monetaryItemType </entity type> <context> Publicly traded equity securities for which we do not have the ability to exercise significant influence are recorded at fair value with changes in fair value recognized in Other (income) expense – net in the Consolidated and Combined Statements of Income. Privately held equity securities for which we do not have the ability to exercise significant influence are accounted for using the measurement alternative approach and are recorded at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, with changes in the measurement recognized through Other (income) expense – net in the Consolidated and Combined Statements of Income. Equity investments without readily determinable fair value as of December 31, 2024 and 2023 were $ 176 million and $ 156 million, respectively. Investment securities are recognized within All other non-current assets in the Consolidated Statements of Financial Position. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
Publicly traded equity securities for which we do not have the ability to exercise significant influence are recorded at fair value with changes in fair value recognized in Other (income) expense – net in the Consolidated and Combined Statements of Income. Privately held equity securities for which we do not have the ability to exercise significant influence are accounted for using the measurement alternative approach and are recorded at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, with changes in the measurement recognized through Other (income) expense – net in the Consolidated and Combined Statements of Income. Equity investments without readily determinable fair value as of December 31, 2024 and 2023 were $ 176 million and $ 156 million, respectively. Investment securities are recognized within All other non-current assets in the Consolidated Statements of Financial Position. | text | 156 | monetaryItemType | text: <entity> 156 </entity> <entity type> monetaryItemType </entity type> <context> Publicly traded equity securities for which we do not have the ability to exercise significant influence are recorded at fair value with changes in fair value recognized in Other (income) expense – net in the Consolidated and Combined Statements of Income. Privately held equity securities for which we do not have the ability to exercise significant influence are accounted for using the measurement alternative approach and are recorded at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, with changes in the measurement recognized through Other (income) expense – net in the Consolidated and Combined Statements of Income. Equity investments without readily determinable fair value as of December 31, 2024 and 2023 were $ 176 million and $ 156 million, respectively. Investment securities are recognized within All other non-current assets in the Consolidated Statements of Financial Position. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
Gains and losses from foreign currency transactions, such as those resulting from the settlement of monetary items in the non-functional currency and those resulting from remeasurements of monetary items, are included in Cost of products, Cost of services, SG&A, and R&D in the Consolidated and Combined Statements of Income, depending on the underlying nature of the item. Net gains (losses) from foreign currency transactions were $ 16 million, $ 16 million, and $( 88 ) million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> Gains and losses from foreign currency transactions, such as those resulting from the settlement of monetary items in the non-functional currency and those resulting from remeasurements of monetary items, are included in Cost of products, Cost of services, SG&A, and R&D in the Consolidated and Combined Statements of Income, depending on the underlying nature of the item. Net gains (losses) from foreign currency transactions were $ 16 million, $ 16 million, and $( 88 ) million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:ForeignCurrencyTransactionGainLossBeforeTax |
Gains and losses from foreign currency transactions, such as those resulting from the settlement of monetary items in the non-functional currency and those resulting from remeasurements of monetary items, are included in Cost of products, Cost of services, SG&A, and R&D in the Consolidated and Combined Statements of Income, depending on the underlying nature of the item. Net gains (losses) from foreign currency transactions were $ 16 million, $ 16 million, and $( 88 ) million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 88 | monetaryItemType | text: <entity> 88 </entity> <entity type> monetaryItemType </entity type> <context> Gains and losses from foreign currency transactions, such as those resulting from the settlement of monetary items in the non-functional currency and those resulting from remeasurements of monetary items, are included in Cost of products, Cost of services, SG&A, and R&D in the Consolidated and Combined Statements of Income, depending on the underlying nature of the item. Net gains (losses) from foreign currency transactions were $ 16 million, $ 16 million, and $( 88 ) million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:ForeignCurrencyTransactionGainLossBeforeTax |
Capitalized costs to obtain a contract were $ 217 million and $ 213 million as of December 31, 2024 and 2023, respectively. Generally, these costs are recognized within two years of being capitalized. When recognized, the costs to obtain a contract are recorded within SG&A in the Consolidated and Combined Statements of Income. | text | 217 | monetaryItemType | text: <entity> 217 </entity> <entity type> monetaryItemType </entity type> <context> Capitalized costs to obtain a contract were $ 217 million and $ 213 million as of December 31, 2024 and 2023, respectively. Generally, these costs are recognized within two years of being capitalized. When recognized, the costs to obtain a contract are recorded within SG&A in the Consolidated and Combined Statements of Income. </context> | us-gaap:CapitalizedContractCostNet |
Capitalized costs to obtain a contract were $ 217 million and $ 213 million as of December 31, 2024 and 2023, respectively. Generally, these costs are recognized within two years of being capitalized. When recognized, the costs to obtain a contract are recorded within SG&A in the Consolidated and Combined Statements of Income. | text | 213 | monetaryItemType | text: <entity> 213 </entity> <entity type> monetaryItemType </entity type> <context> Capitalized costs to obtain a contract were $ 217 million and $ 213 million as of December 31, 2024 and 2023, respectively. Generally, these costs are recognized within two years of being capitalized. When recognized, the costs to obtain a contract are recorded within SG&A in the Consolidated and Combined Statements of Income. </context> | us-gaap:CapitalizedContractCostNet |
As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. | text | 2629 | monetaryItemType | text: <entity> 2629 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerLiability |
As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. | text | 2623 | monetaryItemType | text: <entity> 2623 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerLiability |
As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. | text | 686 | monetaryItemType | text: <entity> 686 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerLiabilityNoncurrent |
As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. | text | 705 | monetaryItemType | text: <entity> 705 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerLiabilityNoncurrent |
As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. | text | 1585 | monetaryItemType | text: <entity> 1585 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. | text | 1554 | monetaryItemType | text: <entity> 1554 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, contract liabilities were approximately $ 2,629 million and $ 2,623 million, respectively, of which the non-current portion of $ 686 million and $ 705 million, respectively, was recognized in All other non-current liabilities in the Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $ 1,585 million and $ 1,554 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
(1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $ 153 million and $ 144 million as of December 31, 2024 and 2023, respectively. | text | 153 | monetaryItemType | text: <entity> 153 </entity> <entity type> monetaryItemType </entity type> <context> (1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $ 153 million and $ 144 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerRefundLiabilityCurrent |
(1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $ 153 million and $ 144 million as of December 31, 2024 and 2023, respectively. | text | 144 | monetaryItemType | text: <entity> 144 </entity> <entity type> monetaryItemType </entity type> <context> (1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $ 153 million and $ 144 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerRefundLiabilityCurrent |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.